Pterin analog for treating BH4 responsive condition

Details for Australian Patent Application No. 2008347005 (hide)

Owner Biomarin Pharmaceutical Inc.

Inventors Kakkis, Emil D.

Agent Griffith Hack

Pub. Number AU-A-2008347005

PCT Pub. Number WO2009/088530

Priority 61/019,753 08.01.08 US; 61/018,735 03.01.08 US

Filing date 7 July 2008

Wipo publication date 16 July 2009

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/088530 Priority application(s): WO2009/088530

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008347006-6-substituted indole-3-carboxylic acid amide compounds having sphingosine1-phosphate (S1P) receptor antagonist biological activity

2008347001-Mobile device management scheduling